Abstract
Beta-thalassemia major patients are treated with repeated blood transfusions, which may cause iron overload, which in turn may induce immune aberrations, and show an increased risk of depression. The aim of the present study is to examine whether repeated blood transfusions, iron overload, and immune-inflammatory responses are associated with depression in children (6–12 years) with transfusion-dependent thalassemia (TDT). The Children’s Depression Inventory (CDI), iron status (serum iron, ferritin, transferrin, TS%), and serum levels of CCL11, IL-1β, IL-10, and TNF-α were measured in TDT with (n = 54) and without (n = 57) a major depression-like episode (MDLE) and in healthy children (n = 55). The results show that MDLE due to TDT is associated with a greater number of blood transfusions and increased iron overload and IL-1β levels. Partial least squares path analysis shows that 68.8% of the variance in the CDI score is explained by the number of blood transfusions, iron overload, and increased levels of IL-1β and TNF-α. The latter two cytokines partly mediate the effects of iron overload on the CDI score, while the effects of blood transfusions on the CDI score are partly mediated by iron overload and the path from iron overload to immune activation. Iron overload is also associated with increased IL-10 and lower CCL11 levels, but these alterations are not significantly associated with depression. In conclusion, blood transfusions may be causally related to MDLE in TDT children and their effects are in part mediated by increased iron overload and the consequent immune-inflammatory response. The results suggest that effects of iron overload and its consequences including inflammation and oxidative stress toxicity may cause MDLE. Current treatment modalities with folic acid and vitamin C are insufficient to attenuate iron overload and immune-inflammatory responses and to prevent MDLE in children with TDT.
Abbreviations
- ANOV:
-
Analysis of variance
- AVE:
-
Average variance extracted
- CCL11:
-
Eotaxin
- CDI:
-
Children’s Depression Inventory
- CIRS:
-
Compensatory immune-regulatory system
- CRP:
-
C-reactive protein
- CV:
-
Coefficient of variance
- ELFA:
-
Enzyme-linked fluorescent immunoassay
- GLM:
-
General linear model
- HPLC:
-
High performance liquid chromatography
- ICD-10-CM:
-
International Classification of Diseases, Tenth Revision, Clinical Modification
- IL:
-
Interleukin
- LSD:
-
Least square difference
- LV:
-
Latent vectors
- MDD:
-
Major depressive disorder
- MDLE:
-
Major depressive-like episodes
- PLS:
-
Partial least squares
- SE:
-
Standard error
- SRMR:
-
Standardized root mean squared residual
- TDT:
-
Transfusion-dependent thalassemia
- Th:
-
T helper cells
- TIBC:
-
Total iron-binding capacity
- TNF-α:
-
Tumor-necrosis factor-α
- Treg:
-
T regulatory
- TS%:
-
Transferrin saturation percentage
- UIBC:
-
Unsaturated iron-binding capacity
References
Abdulzahra MS, Al-Hakeim HK, Ridha MM (2011) Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients. Asian J Transfus Sci 5:127–131
Agrawal S, Berggren KL, Marks E, Fox JH (2017) Impact of high iron intake on cognition and neurodegeneration in humans and in animal models: A systematic review. Nutrition reviews 75:456–470
Al-Hakeim HK, Almulla AF, Maes M (2020) The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study. Neurotox Res. https://doi.org/10.1007/s12640-019-00112-z
Al-Hakeim HK, Al-Khakani MM, Al-Kindi MA (2015) Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia. Adv Clin Exp Med 24:69–78
Atasever B, Ertan NZ, Erdem-Kuruca S, Karakas Z (2006) In vitro effects of vitamin C and selenium on NK activity of patients with beta-thalassemia major. Pediatr Hematol Oncol 23:187–197
Baghersalimi A, Hemmati KH, Darbandi B, Kamran MZ, Alizadeh AM, Dalili S et al (2018) Assessment of serum folic acid and homocysteine in thalassemia major patients before and after folic acid supplement cessation. J Pediatr Hematol Oncol 40:504–507
Balouchi S, Gharagozloo M, Esmaeil N, Mirmoghtadaei M, Moayedi B (2014) Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy. Immunopharmacol Immunotoxicol 36:271–274
Bender LM, Morgan MJ, Thomas LR, Liu ZG, Thorburn A (2005) The adaptor protein TRADD activates distinct mechanisms of apoptosis from the nucleus and the cytoplasm. Cell Death Differ 12:473–481
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Royal Statis Soc B 57:289–300
Boyer TD, Habib S (2015) Big spleens and hypersplenism: fix it or forget it? Liver Int 35:1492–1498
Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12:61–76
Capellini M, Cohen A, Eleftheriou A (2008) Guidelines for the clinical management of thalassemia (2nd revised edition), Nicosia. 2008.
Chang JS, Li YL, Lu CH, Owaga E, Chen WY, Chiou HY (2014) Interleukin-10 as a potential regulator of hepcidin homeostasis in overweight and obese children: a cross-sectional study in Taiwan. Nutrition 30:8099–9007
Chao CC, Hu S, Ehrlich L, Peterson PK (1995) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9:355–365
Chern JP, Su S, Lin KH, Chang SH, Lu MY, Jou ST, Lin DT, Ho WL, Lin KS (2007) Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan. Pediatr Blood Cancer 48:550–554
Cook JD, Lipschitz DA, Miles LEM, Finch CA (1974) Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 27:681–687
Crichton R, Ward R (2013) Metal-based neurodegeneration: From molecular mechanisms to therapeutic strategies, 2nd edn. John Wiley & Sons
Cutler P (1994) Iron overload and psychiatric illness. Can J Psychiatr 39:8–11
Daher R, Manceau H, Karim Z (2017) Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease. Presse Med 46:e272–e278
Ezer U, Gulderen F, Culha VK, Akgül N, Gürbüz O (2002) Immunological status of thalassemia syndrome. Pediatr Hematol Oncol 19:51–58
Farmakis D, Giakoumis A, Polymeropoulos E, Aessopos A (2003) Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit 9:RA19–RA22
Gan GG, Hue YL, Sathar J (2016) QOL of adult patients with Thalassaemi. Ann Acad Med 45:520–523
Ghaffari J, Vahidshahi K, Kosaryan M, Soltantooyeh Z, Mohamadi M (2011) Humeral immune system state in β thalassemia major. Med Glas Ljek Komore Zenickodoboj kantona 8:192–196
Ghanizadeh A, Khajavian S, Ashkani H (2006) Prevalence of psychiatric disorders, depression, and suicidal behavior in child and adolescent with thalassemia major. J Pediatr Hematol Oncol 28:781–784
Gharagozloo M, Bagherpour B, Tahanian M, Oreizy F, Amirghofran Z, Sadeghi HM, Hourfar H, Moayedi B (2009a) Premature senescence of T lymphocytes from patients with beta-thalassemia major. Immunol Lett 122:84–88
Gharagozloo M, Karimi M, Amirghofran Z (2009b) Double-faced cellmediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity. Ann Hematol 88:21–27
Grassi-Oliveira R, Brieztke E, Teixeira A, Pezzi JC, Zanini M, Lopes RP, Bauer ME (2012) Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Braz J Psychiatry 34:71–75
Guo H, Jin YX, Ishikawa M, Huang YM, van der Meide PH, Link H, Xiao BG (1998) Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines. Scand J Immunol 48:502–508
Hagag AA, El-Shanshory MR, AboEl-Enein AM (2015) Parathyroid function in children with beta thalassemia and correlation with iron load. Adv Pediatr Res 2:3
Hamed AA, Elguindy W, Elhenawy YI, Ibrahim RH (2016) Early cardiac involvement and risk factors for the development of arrhythmia in patients with β-thalassemia major. J Pediatr Hematol Oncol 38:5–11
Hammond J, Thompson AA, Fogel MA, Hammond K, Kokroko J, Kwiatkowski JL (2019) Combination oral chelation in adult patients with transfusion-dependent thalassemia and high Iron burden. J Pediatr Hematol Oncol 41:e47–e50
Hasiloglu ZI, Asik M, Ure E, Ertem F, Apak H, Albayram S (2017) The utility of susceptibility-weighted imaging to evaluate the extent of iron accumulation in the choroid plexus of patients with β-thalassaemia major. Clin Radiol 72(10):903.e1–903.e7
Javad G, Saeid A, Mohammadmehdi N (2011) Thalassemia and immune system dysfunction-review article. IJCR 3:105–108
Jomova K, Valko M (2011) Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des 17:3460–3473
Kennedy A, Kohn M, Lammi A, Clarke S (2004) Iron status and haematological changes in adolescent female inpatients with anorexia nervosa. J Paediatr Child Health 40:430–432
Keskek SO, Kirim S, Turhan A, Turhan FG (2013) Depression in subjects with beta-thalassemia minor. Ann Hematol 92:1611–1615
Khoury B, Musallam KM, Abi-Habib R, Bazzi L, Ward Z, Succar J, Halawi R, Hankir A, Koussa S, Taher AT (2012) Prevalence of depression and anxiety in adult patients with ß-thalassemia major and intermedia. Int J Psychiatry Med 44:291–303
Kim J, Wessling-Resnick M (2014) Iron and mechanisms of emotional behavior. J Nutr Biochem 25:1101–1107
Koutelekos J, Haliasos N (2013) Depression and thalassemia in children, adolescents and adults. Health Sci J 7:239–246
Kovacs M (1992) Children’s depression inventory manual. Multi-health Systems, New York
Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C (2005) Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci 1054:445–450
Leonard B, Maes M (2012) Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36:764–785
Liaska A, Petrou P, Georgakopoulos CD, Diamanti R, Papaconstantinou D, Kanakis MG et al (2016) β-Thalassemia and ocular implications: a systematic review. BMC Ophthalmol 16:102
Libani IV, Guy EC, Melchiori L, Schiro R, Ramos P, Breda L, Scholzen T, Chadburn A, Liu Y, Kernbach M, Baron-Lühr B, Porotto M, de Sousa M, Rachmilewitz EA, Hood JD, Cappellini MD, Giardina PJ, Grady RW, Gerdes J, Rivella S (2008) Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia. Blood 112:875–885
Lombardi G, Matera R, Minervini MM, Cascavilla N, D’Arcangelo P, Carotenuto M et al (1994) Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status. Haematologica 79:406–412
Maes M, Carvalho AF (2018) The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol 55:8885–8903
Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J (1991) Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84:379–386
Maes M, Stevens WJ, Declerck LS, Bridts CH, Peeters D, Schotte C, Cosyns P (1993) Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness. Prog Neuro-Psychopharmacol Biol Psychiatry 17:241–255
Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A et al (1996) Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. J Affect Disord 40:23–33
Maes M, Bosmans E, Scharpé S, Hendriks D, Cooremans W, Neels H, de Meyer F, D'Hondt P, Peeters D (1997) Components of biological variation in serum soluble transferrin receptor: relationships to serum iron, transferrin and ferritin concentrations, and immune and haematological variables. Scand J Clin Lab Invest 57:31–41
Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M (2012) New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 20:127–150
Magalhaes PV, Jansen K, Stertz L, Ferrari P, Pinheiro RT, da Silva RA, Kapczinski F (2014) Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults. J Psychiatr Res 48:13–15
Manara R, Ponticorvo S, Tartaglione I, Femina G, Elefante A, Russo C et al (2019) Brain iron content in systemic iron overload: a beta-thalassemia quantitative MRI study. Neuroimage Clin 24:102058
Maras JS, Das S, Sharma S, Sukriti S, Kumar J, Vyas AK, Kumar D, Bhat A, Yadav G, Choudhary MC, Sharma S, Kumar G, Bihari C, Trehanpati N, Maiwall R, Sarin SK (2018) Iron-overload triggers ADAM-17 mediated inflammation in severe alcoholic hepatitis. Sci Rep 8:10264. https://doi.org/10.1038/s41598-018-28483-x
McLaren CE, Li KT, Gordeuk VR, Hasselblad V, McLaren GD (2001) Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey. Blood 98:2345–2351
Messina G, Colombo E, Cassinerio E, Ferri F, Curti R, Altamura C et al (2008) Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Intern Emerg Med 2008:339–343
Metafratzi Z, Argyropoulou MI, Kiortsis DN, Tsampoulas C, Chaliassos N, Efremidis SC (2001) T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassemia major. Br J Radiol 74:407–410
Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001) Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11:203–208
Moris W, Verhaegh P, Jonkers D, Deursen CV, Koek G (2019) Hyperferritinemia in nonalcoholic fatty liver disease: iron accumulation or inflammation? Semin Liver Dis 39:476–482
Morris G, Berk M, Carvalho AF, Maes M, Walker AJ, Puri BK (2018) Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiolaogy of neuroprogressive diseases. Behav Brain Res 341:154–175
Nnah IC, Wessling-Resnick M (2018) Brain iron homeostasis: A focus on microglial iron. Pharmaceuticals 11:129
O’Brien-Ladner AR, Nelson SR, Murphy WJ, Blumer BM, Wesselius LJ (2000) Iron is a regulatory component of human IL-1 β production: Support for regional variability in the lung. Am J Respir Cell Mol Biol 23:112–119
Premawardhena A, Ranawaka U, Pilapitiya T, Weerasinghe G, Hapangama A, Hettiarachchi S (2019) Headache: an important symptom possibly linked to white matter lesions in thalassaemia. Br J Haematol 185(3):541–548
Qiu D, Chan GC, Chu J, Chan Q, Ha SY, Moseley ME, Khong PL (2014) MR quantitative susceptibility imaging for the evaluation of iron loading in the brains of patients with β-thalassemia major. AJNR Am J Neuroradiol 35(6):1085–1090
Ricerca BM, DiGirolamo A, Rund D (2009) Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. Mediterr J Hematol Infect Dis 1:e2009028
Richardson AC, Heath AM, Haszard JJ, Polak MA, Houghton LA, Conner TS (2015) Higher body iron is associated with greater depression symptoms among young adult men but not women: observational data from the daily life study. Nutrients 7:6055–6072
Ringle CM, Wende S, Becker J-M (2015) SmartPLS 3. SmartPLS, Bönningstedt Retrieved from http://www.smartpls.com
Russo AG, Ponticorvo S, Tartaglione I, Caiazza M, Roberti D, Elefante A et al (2019) No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses. Blood Cells Mol Dis 78:9–13
Rybka J, Kędziora-Kornatowska K, Banaś-Leżańska P, Majsterek I, Carvalho LA, Cattaneo A, Anacker C, Kędziora J (2013) Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression. Free Radic Biol Med 63:187–194
Sari TT, Gatot D, Akib AA, Bardosono S, Hadinegoro SR, Harahap AR, Idjradinata PS (2014) Immune response of thalassemia major patients in Indonesia with and without splenectomy. Acta Med Indones 46:217–225
Schneider SA, Bhatia KP (2013) Excess iron harms the brain: The syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA). J Neural Transm 120:695–703
Shafiee A, Nazari S, Jorjani S, Bahraminia E, Sadeghi-Koupaei M (2014) Prevalence of depression in patients with β-thalassemia as assessed by the Beck’s depression inventory. Hemoglobin 38:289–291
Shah FT, Sayani F, Trompeter S, Drasar E, Piga A (2019) Challenges of blood transfusions in β-thalassemia. Blood Rev 100588:100588. https://doi.org/10.1016/j.blre.2019.100588
Sherief LM, Abd El-Salam SM, Kamal NM, El-Safy O, Almalky MA, Azab SF et al (2014) Nutritional biomarkers in children and adolescents with Beta-thalassemia-major: an Egyptian center experience. Biomed Res Int 2014:261761
Siesjö B, Agardh CD, Bengtsson F (1989) Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1(3):165–211
Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack M, Nierenberg AA, Fava M, Wong KK (2008) A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol 18:230–233
Stockings E, Degenhardt L, Lee YY, Mihalopoulos C, Liu A, Hobbs M, Patton G (2015) Symptom screening scales for detecting major depressive disorder in children and adolescents: a systematic review and meta-analysis of reliability, validity and diagnostic utility. J Affect Disord 174:447–463
Suriapperuma T, Peiris R, Mettananda C, Premawardhena A, Mettananda S (2018) Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control. BMC Res Notes 11:547
Taher AT, Saliba AN (2017) Iron overload in thalassemia: different organs at different rates. Hematol Am Soc Hematol Educ Program 2017:265–271
Tartaglione I, Caiazza M, Di Concilio R, Ciancio A, De Michele E, Maietta C et al (2019) Headache in beta-thalassemia: an Italian multicenter clinical, conventional MRI and MR-angiography case-control study. Blood Cells Mol Dis 81:102403
Thein SL (2013) The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med 3:a011700
Tietz NW, Rinker AD, Morrison SR (1994) When is a serum iron really a serum iron? The status of serum iron measurements. Clin Chem 40:546–551
Wahidiyat PA, Sastroasmoro S, Fucharoen S, Setianingsih I, Putriasih S (2018) Applicability of a clinical scoring criteria for disease severity of ß-thalassemia/ hemoglobin E in Indonesia. Med J Indones 27:26–32
Walker EM, Walker SM (2000) Effects of iron overload on the immune system. Ann Clin Lab Sci 30:354–365
Wessling-Resnick M (2010) Iron homeostasis and the inflammatory response. Annu Rev Nutr 30:105–122
Witzleben CL, Wyatt JP (1961) The effect of long survival on the pathology of thalassæmia major. J Pathol Bacteriol 82:1–12
Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26:165–176
Yang H, Yang M, Guan H, Liu Z, Zhao S, Takeuchi S, Yanagisawa D, Tooyama I (2013) Mitochondrial ferritin in neurodegenerative diseases. Neurosci Res 77:1–7
Yengil E, Acipayam C, Kokacya MH, Kurhan F, Oktay G, Ozer C (2014) Anxiety, depression and quality of life in patients with beta thalassemia major and their caregivers. Int J Clin Exp Med 7:2165–2172
Zhou Y, Que K, Zhang Z, Yi ZJ, Zhao PX, You Y, Gong J, Liu Z (2018) Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway. Cancer Med 7:4012–4022
Acknowledgments
We thank the staff of the Thalassemia Unit at Al-Zahra’a Teaching Hospital-Najaf city-Iraq for their help in the collection of samples. We also acknowledge the work of the highly skilled staff of the Asia Laboratory in measuring the biomarkers.
Author information
Authors and Affiliations
Contributions
All the contributing authors have participated in the preparation of the manuscript.
Corresponding author
Ethics declarations
The study was approved by the IRB of University of Kufa number 487/2018.
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Al-Hakeim, H.K., Najm, A.H., Al-Dujaili, A.H. et al. Major Depression in Children with Transfusion-Dependent Thalassemia Is Strongly Associated with the Combined Effects of Blood Transfusion Rate, Iron Overload, and Increased Pro-inflammatory Cytokines. Neurotox Res 38, 228–241 (2020). https://doi.org/10.1007/s12640-020-00193-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-020-00193-1